Averin Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 10, 2026

Rhea-AI Summary

Averin Capital Acquisition Corp (Nasdaq: ACAAU) said that beginning April 10, 2026 holders of IPO units may elect to separately trade the Company’s Class A ordinary shares and warrants. No fractional warrants will be issued; only whole warrants will trade.

Separated Class A shares will trade as ACAA and warrants as ACAAW; unsplit units remain under ACAAU.

News Market Reaction – ACAAU

-0.50%

-0.50% Session close to close

In the Apr 9 session, ACAAU declined 0.50%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New York, NY, April 08, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (Nasdaq: ACAAU) (the “Company”) announced today that, commencing April 10, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “ACAA” and “ACAAW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “ACAAU.”

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Averin Capital Acquisition Corp.

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company currently intends to concentrate its efforts in identifying businesses that are at the intersection of the technology and health industries.

Forward-Looking Statements

This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact

Averin Capital Acquisition Corp.
David Berry, Chief Executive Officer
david@averincapital.com

FAQ

When will Averin Capital (ACAAU) allow separate trading of shares and warrants?

Separate trading begins on April 10, 2026, allowing units to be split into shares and warrants. According to the company, holders of IPO units may elect separation starting that date, and separated securities will trade under new Nasdaq symbols.

What Nasdaq symbols will Averin Capital's separated securities trade under?

The separated Class A ordinary shares will trade as ACAA and the warrants as ACAAW. According to the company, units that remain together will continue trading as ACAAU on the Nasdaq Global Market.

Will fractional warrants be issued when Averin Capital (ACAAU) units are split?

No fractional warrants will be issued upon separation; only whole warrants will trade. According to the company, holders should expect that fractions will not be distributed and only integer warrants will appear in trading.

If I don’t separate my ACAAU units, what happens after April 10, 2026?

Units that are not separated will continue trading as ACAAU on Nasdaq. According to the company, holders who do not elect separation will retain their units under the existing ticker without creating separate share or warrant lines.

How can investors elect to separate Averin Capital units into ACAA and ACAAW?

Investors should follow their broker’s procedures to elect separation before or on April 10, 2026. According to the company, holders of the IPO units may elect through their brokerage to effect the separation and begin trading the individual securities.

Does the Averin Capital announcement constitute an offer to buy or sell securities?

No, the announcement is not an offer or solicitation to buy or sell securities and is subject to legal restrictions. According to the company, any sale would be unlawful in jurisdictions lacking proper registration or qualification.